The Latin America, Middle East and Africa HIV Injection Market would witness market growth of 19.8% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA HIV Injection Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $52.8 Million by 2029. The Argentina market is showcasing a CAGR of 20.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 19.4% during (2023 - 2030).
Studies have shown that adherence to oral antiretroviral therapy can be challenging for some patients, leading to suboptimal treatment outcomes and an increased risk of developing drug resistance. Injectable treatments, by contrast, are administered by healthcare providers, which can help ensure that patients receive their medications as prescribed. This can be especially important for patients who may struggle with adherence or who may be at risk of forgetting to take their medications.
The development of new antiretroviral drugs and treatment regimens has expanded the options available for injectable treatments, providing patients with more effective and convenient treatment options. One of the key advancements in HIV treatment has been the development of long-acting injectable therapies. These medications are administered less frequently than traditional oral medications, ranging from once a week to once every few months, depending on the specific drug.
Sub-Saharan Africa is classified as the region with the highest prevalence rates of HIV/AIDS on a global scale, with certain countries within the area bearing the brunt of this burden. For example, countries in southern Africa, such as South Africa, Swaziland, and Lesotho, have among the highest prevalence rates in the world. Hence, all of these factors will significantly support the expansion of the market in this region.
Free Valuable Insights: The Worldwide HIV Injection Market is Projected to reach USD 2.8 Billion by 2030, at a CAGR of 17.6%
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Distribution Channel
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
